
    
      Within 3 weeks prior to the first administration of study drug, volunteers who agreed the
      participation of this study by their written consent will undergo screening, including
      physical examination and clinical laboratory test etc, to evaluate whether they are eligible
      to participate in this study. Study drugs will be administered at about 8 A.M. in the morning
      of the drug administration day, followed by blood collection for evaluation of
      pharmacokinetics. The same schedule with increased dose will be proceeded after 14-day
      washout period.
    
  